LKB1 gene inactivation does not sensitize non-small cell lung cancer cells to mTOR inhibitors in vitro

被引：0
|
作者：
Ping Xiao
Lin-lin Sun
Jing Wang
Rui-li Han
Qing Ma
Dian-sheng Zhong
机构：
[1] Tianjin Medical University General Hospital,Department of Oncology
[2] Tianjin Lung Cancer Institute,undefined
[3] Tianjin Medical University General Hospital,undefined
来源：
Acta Pharmacologica Sinica | 2015年 / 36卷
关键词：
non small-cell lung cancer; mTOR protein; liver kinase B1; AKT; rapamycin; RAD001; LY294002;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1107 / 1112
页数：5
相关论文
共 50 条
  • [1] LKB1 gene inactivation does not sensitize non-small cell lung cancer cells to mTOR inhibitors in vitro
    Xiao, Ping
    Sun, Lin-lin
    Wang, Jing
    Han, Rui-li
    Ma, Qing
    Zhong, Dian-sheng
    ACTA PHARMACOLOGICA SINICA, 2015, 36 (09) : 1107 - 1112
  • [2] LKB1 inactivation sensitizes non-small cell lung cancer to pharmacological aggravation of ER stress
    Inge, Landon J.
    Friel, Jacqueline M.
    Richer, Amanda L.
    Fowler, Aaron J.
    Whitsett, Timothy
    Smith, Michael A.
    Tran, Nhan L.
    Bremner, Ross M.
    CANCER LETTERS, 2014, 352 (02) : 187 - 195
  • [3] LKB1 loss is associated with resistance to VEGF inhibitors in non-small cell lung cancer (NSCLC)
    Guijarro, Irene
    Poteete, Alissa
    Yang, Chao
    Roarty, Emily
    Nilsson, Monique
    Sun, Huiying
    Tong, Pan
    Chang, Edward
    Rodriguez-Canales, Jaime
    Mino, Barbara
    Parra, Edwin
    Wistuba, Ignacio
    Wang, Jing
    Heffernan, Timothy
    Heymach, John V.
    CANCER RESEARCH, 2016, 76
  • [4] LKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug Phenformin
    Shackelford, David B.
    Abt, Evan
    Gerken, Laurie
    Vasquez, Debbie S.
    Seki, Atsuko
    Leblanc, Mathias
    Wei, Liu
    Fishbein, Michael C.
    Czernin, Johannes
    Mischel, Paul S.
    Shaw, Reuben J.
    CANCER CELL, 2013, 23 (02) : 143 - 158
  • [5] LKB1/AMPK/mTOR Signaling Pathway in Non-small-cell Lung Cancer
    Han, Dong
    Li, Shao-Jun
    Zhu, Yan-Ting
    Liu, Lu
    Li, Man-Xiang
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (07) : 4033 - 4039
  • [6] LKB1 loss sensitizes non-small cell lung cancer cells to aggravation of ER stress
    Inge, Landon J.
    Friel, Jacqueline M.
    Fowler, Aaron
    Richer, Amanda
    Whitsett, Timothy
    Tran, Nhan L.
    Bremner, Ross M.
    CANCER RESEARCH, 2014, 74 (19)
  • [7] LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-Small Cell Lung Cancer Plasticity and Therapeutic Response
    Li, Fuming
    Han, Xiangkun
    Li, Fei
    Wang, Rui
    Li, Yuan
    Wong, Kowk-Kin
    Chen, Haiquan
    Ji, Hongbin
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S473 - S474
  • [8] LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-small Cell Lung Cancer Plasticity and Therapeutic Response
    Li, Fuming
    Han, Xiangkun
    Li, Fei
    Wang, Rui
    Wang, Hui
    Gao, Yijun
    Wang, Xujun
    Fang, Zhaoyuan
    Zhang, Wenjing
    Yao, Shun
    Tong, Xinyuan
    Wang, Yuetong
    Feng, Yan
    Sun, Yihua
    Li, Yuan
    Wong, Kwok-Kin
    Zhai, Qiwei
    Chen, Haiquan
    Ji, Hongbin
    CANCER CELL, 2015, 27 (05) : 698 - 711
  • [9] LKB1 as the keyregulator of non-small cell lung cancer plasticity and therapeutic response
    Science Foundation in China, 2015, (03) : 15 - 15
  • [10] Mutations of the LKB1/STK11 gene in non-small cell lung cancer with loss of heterozygosity
    Yang, Sei-Hoon
    Meerzaman, Daoud
    Mechanic, Leah E.
    Gill, Rajbir
    Dracheva, Tatiana
    Han, Seung-Bum
    Kim, Sam-Yong
    Bowman, Elise D.
    Harris, Curtis C.
    Jen, Jin
    ANNALS OF ONCOLOGY, 2006, 17 : 246 - 246
12345